Cytokine patterns in patients with cancer: a systematic review.

By B. Lippitz. The Lancet Oncology, 2013

856 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/a54350c29741bba96afdefab4ae13e1fc09cced5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Daniel S. Chen
2. Bostjan Seruga
3. T. Whiteside
4. I. Mellman
5. I. Tannock

In Oncology

1. Daniel S. Chen
2. Bostjan Seruga
3. Chun-Lei Jiang
4. T. Whiteside
5. S. Evans
6. D. Fisher
7. Yun-xia Wang
8. I. Mellman

In Rheumatology

1. T. Whiteside
2. Daniel S. Chen
3. I. Mellman

Citations in the corpus

• The Two Faces of IL-6 in the Tumor Microenvironment (2014, background): “Particularly damning are studies revealing that high serum concentration of IL-6 is a prognostic indicator of poor outcome in cancer patients with diverse histological tumor types including gastric, pancreatic, melanoma, breast, colorectal, myeloma, and lung cancer [23,24].”
• Oncology meets immunology: the cancer-immunity cycle. (2013, background): “Similarly, B-Raf inhibitors (vemurafenib) may also enhance T cell infiltration into tumors (Liu et al., 2013).”
• Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis (2014, background): “the differentiation of megakaryocytes to platelets and is involved in recruitment of neutrophils (21, 22).”
• Tumor-derived exosomes and their role in cancer progression (2016, background): “Specifically, CAF acquire the characteristics of activated fibroblasts and increase the production of collagen and hyaluronic acid [76].”
• Inflammation: The Common Pathway of Stress-Related Diseases (2017, background): “…| Volume 11 | Article 316 Several studies revealed that high serum concentration of IL-6 is a prognostic indicator of poor outcome in cancer patients with diverse tumor types including gastric, pancreatic, melanoma, breast, colorectal, myeloma and lung cancer (Heikkilä et al., 2008; Lippitz, 2013).”
• Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. (2014, background): “Serum concentrations of IL-6 have been shown to be increased in 13 different cancer types and have been associated with tumor stage and adverse prognosis (29).”